ARS Pharmaceuticals, Inc. SPRY Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s book value per share?
- ARS Pharmaceuticals, Inc. (SPRY) reported book value per share of $0.62 in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s book value per share changed year-over-year?
- ARS Pharmaceuticals, Inc.'s book value per share decreased by 73.6% year-over-year, from $2.34 to $0.62.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s book value per share?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s book value per share has grown at a -24.8% compound annual growth rate (CAGR), from -$4.83 to $1.16.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.